John R. Guyton

16.1k citations

166 papers · 12.0k indexed · 6 hit papers · h-index 53

Impact in

Endocrinology, Diabetes and Metabolism top 0.2%
- Diabetes, Cardiovascular Risks, and Lipoproteins
Surgery top 0.2%
- Lipoproteins and Cardiovascular Health
- Cholesterol and Lipid Metabolism

Papers in

Endocrinology, Diabetes and Metabolism 70
- Diabetes, Cardiovascular Risks, and Lipoproteins 58
Surgery 109
- Lipoproteins and Cardiovascular Health 93

Co-authors: K F Klemp Terry A. Jacobson Antonio M. Gotto J A Kautz G. Dahlén Eric C. Westman Maren K. Olsen William S. Yancy
Journals: Journal of clinical lipidology (46 papers)The American Journal of Cardiology (18 papers)Journal of the American College of Cardiology (4 papers)Circulation (3 papers)Atherosclerosis (3 papers)
Partner nations: United States Canada France

In The Last Decade

John R. Guyton

161 papers receiving 11.5k citations

Hit Papers

6 papers align trajectories log scale

Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial 2015 · 345 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 Journal of clinical lipidology
2006 Stroke
2004 Annals of Internal Medicine
1994 Arteriosclerosis and Thrombosis A Journal of Vascular Biology
1994 Circulation
1986 Circulation

Peers

Countries citing papers authored by John R. Guyton

Since Specialization

Citations

This map shows the geographic impact of John R. Guyton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Guyton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Guyton more than expected).

Fields of papers citing papers by John R. Guyton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Guyton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Guyton. The network helps show where John R. Guyton may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John R. Guyton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John R. Guyton Line = papers co-authored together John R. Guyton links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Offshore World According to FATCA: New Evidence on the Foreign Wealth of US Households Tax Policy and the Economy ·Niels Johannesen, Daniel Reck, Jantammy Roinatal Munthe, Joel Slemrod, John R. Guyton, Patrick Langetieg	2024	2
2	Niacin, food intake and cardiovascular effects Nature Medicine ·John R. Guyton, William E. Boden	2024	2
3	JCL Roundtable: Lipidology and Women's Health Journal of clinical lipidology ·Eugenia Gianos, Emily S. Lau, Samar R. El Khoudary, John R. Guyton	2023	3
4	JCL Roundtable. Obesity, Diabetes, and Liver Disease in Relation to Cardiovascular Risk Journal of clinical lipidology ·Kathleen Wyne, Sheldon E. Litwin, Kenneth Cusi, John R. Guyton	2022	2
5	JCL Roundtable. Making prevention a priority Journal of clinical lipidology ·Anandita Agarwala, Anne C. Goldberg, Christie M. Ballantyne, John R. Guyton	2021	2
6	Review article: the impact of liver‐directed therapies on the atherogenic risk profile in non‐alcoholic steatohepatitis Alimentary Pharmacology & Therapeutics ·Margery A. Connelly, Rifat OLGUN, John R. Guyton, Mohammad Shadab Siddiqui, Arun J. Sanyal	2020	7
7	JCL roundtable: Low-carbohydrate diets Journal of clinical lipidology ·Jackie L. Boucher, Carol F Kirkpatrick, David S. Ludwig, John R. Guyton	2020	2
8	PCSK9 inhibitors for prevention of atherosclerotic cardiovascular disease Journal of clinical lipidology ·Vera Bittner, Robert P. Giugliano, Eliot A. Brinton, John R. Guyton	2018	10
9	An assessment by the Statin Intolerance Panel: 2014 update Journal of clinical lipidology ·John R. Guyton, Harold Bays, Scott M. Grundy, Terry A. Jacobson	2014	128
10	Inherited lipemic splenomegaly and the spectrum of apolipoprotein E p.Leu167del mutation phenotypic variation Journal of clinical lipidology ·Daniel Okorodudu, Matthew J. Crowley, Siby Sebastian, Jennifer Rowell, John R. Guyton	2013	5
11	Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemia Atherosclerosis ·Michel Farnier, John R. Guyton, Erin Jensen, Adam B. Polis, Amy O. Johnson‐Levonas, Philippe Brudi	2013	12
12	Relationship of Lipoproteins to Cardiovascular Events Journal of the American College of Cardiology ·John R. Guyton, April Slee, Todd J. Anderson, Jerome L. Fleg, Ronald Goldberg, Moti L. Kashyap, Santica M. Marcovina, Stephen D. Nash, Kevin D. O’Brien, William S. Weintraub, Ping Xu, Xue-Qiao Zhao, William E. Boden	2013	140
13	Serum apolipoprotein C-III is independently associated with chronic hepatitis C infection and advanced fibrosis Hepatology International ·Jennifer Rowell, Julien Dovale, John R. Guyton, Xiang Qian Lao, John G. McHutchison, Jeanette McCarthy, Keyur Patel	2011	15
14	Genome-Wide Association Study of Lp-PLA2 Activity and Mass in the Framingham Heart Study PLoS Genetics ·Sunil Suchindran, J. Herick, John R. Guyton, Patrick Ryan Samoza, Xiaoyi Gao, Т.И Гусева, Jennifer Rowell, Geoffrey S. Ginsburg, Jeanette McCarthy	2010	59
15	Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Coadministered With Extended-Release Niacin in Patients With Type IIa or Type IIb Hyperlipidemia Journal of the American College of Cardiology ·John R. Guyton, B. Greg Brown, Sergio Fazio, Adam B. Polis, Joanne E. Tomassini, Andrew M. Tershakovec	2008	67
16	Primary Prevention of Ischemic Stroke Stroke ·Larry B. Goldstein, Robert J. Adams, Mark J. Alberts, Lawrence J. Appel, Lawrence Brass, Cheryl Bushnell, Antonio Culebras, Thomas J. DeGraba, Philip B. Gorelick, John R. Guyton, Robert G. Hart, George Howard, Margaret Kelly‐Hayes, J.V. Nixon, Ralph L. Sacco Hit paper breakdown →	2006	1002
17	Benefit versus Risk in Statin Treatment The American Journal of Cardiology ·John R. Guyton	2006	58
18	Effect of niacin on atherosclerotic cardiovascular disease The American Journal of Cardiology ·John R. Guyton	1998	50
19	Lovastatin increases exercise-induced skeletal muscle injury Metabolism ·Paul D. Thompson, Joseph M. Zmuda, R. Ramos-Pollant, Guodong Kang, Joan E. Staggers, John R. Guyton	1997	143
20	The coronary artery response to implantation of a balloon-expandable flexible stent in the aspirin- and non-aspirin-treated swine model American Heart Journal ·George P. Rodgers, Steven T. Minor, Keith A. Robinson, Douglas M. Cromeens, L. Clifton Stephens, Jude Chinedu, John R. Guyton, Kenneth C. Wright, Robert J. Siegel, Gary S. Roubin, Albert E. Raizner	1991	23

About John R. Guyton

John R. Guyton is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Biochemistry, Cancer Research and Cardiology and Cardiovascular Medicine, having authored 166 papers that have together received 12.0k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (93 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (58 papers), Cancer, Lipids, and Metabolism (25 papers), Atherosclerosis and Cardiovascular Diseases (16 papers), Health Systems, Economic Evaluations, Quality of Life (15 papers), Pharmaceutical Economics and Policy (13 papers), Antioxidant Activity and Oxidative Stress (12 papers) and Diet and metabolism studies (11 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.3k citations), Surgery (6.2k citations), Cancer Research (1.8k citations), Cardiology and Cardiovascular Medicine (2.5k citations) and Biochemistry (490 citations). John R. Guyton has collaborated with scholars based in United States, Canada and France. Frequent co-authors include K F Klemp, Terry A. Jacobson, Antonio M. Gotto, J A Kautz, G. Dahlén, Eric C. Westman, Maren K. Olsen, William S. Yancy, Margaret Rosenfeld and William D. Wagner. Their work appears in journals such as Journal of clinical lipidology, The American Journal of Cardiology, Journal of the American College of Cardiology, Circulation and Atherosclerosis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact